|
1
|
Thun MJ, DeLancey JO, Center MM, et al:
The global burden of cancer: priorities for prevention.
Carcinogenesis. 31:100–110. 2010. View Article : Google Scholar :
|
|
2
|
Jemal AB, Bray F, Center M, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schütte K, Bornschein J and Malfertheiner
P: Hepatocellular carcinoma-epidemiological trends and risk
factors. Dig Dis. 27:80–92. 2009. View Article : Google Scholar
|
|
4
|
Sherman M: Hepatocellular carcinoma.
epidemiology, risk factors and screening. Semin Liver Dis.
25:143–154. 2005. View Article : Google Scholar
|
|
5
|
Hiratsuka S: Vasculogenensis, angiogenesis
and special features of tumor blood vessels. Front Biosci (Landmark
Ed). 16:1413–1427. 2010. View
Article : Google Scholar
|
|
6
|
Lim CS, Kiriakidis S, Sandison A, et al:
Hypoxia-inducible factor pathway and diseases of the vascular wall.
J Vasc Surg. 58:219–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang F, Tang YT, Guo L and Jiao XY: The
role of insulin-like growth factor I and hypoxia inducible factor
1α in vascular endothelial growth factor expression in type 2
diabetes. Ann Clin Lab Sci. 43:37–44. 2013.PubMed/NCBI
|
|
8
|
Hervouet E, Pecina P, Demont J, et al:
Inhibition of cytochrome c oxidase subunit 4 precursor processing
by the hypoxia mimic cobalt chloride. Biochem Biophys Res Commun.
344:1086–1093. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeon ES, Shin JH, Hwang SJ, et al: Cobalt
chloride induces neuronal differentiation of human mesenchymal stem
cells through upregulation of microRNA-124a. Biochem Biophys Res
Commun. 444:581–587. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Wang C, Wang Y, et al: Cobalt
chloride decreases fibroblast growth factor-21 expression dependent
on oxidative stress but not hypoxia-inducible factor in Caco-2
cells. Toxic Appl Pharmacol. 264:212–221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wülfing P, Götte M, Sonntag B, et al:
Overexpression of Endothelin-A-receptor in breast cancer:
regulation by estradiol and cobalt-chloride induced hypoxia. Int J
Oncol. 26:951–960. 2005.PubMed/NCBI
|
|
12
|
Rosmorduc O and Housset C: Hypoxia: a link
between fibrogenesis, angiogenesis, and carcinogenesis in liver
disease. Semin Liver Dis. 30:258–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shojaei F: Anti-angiogenesis therapy in
cancer: current challenges and future perspectives. Cancer Lett.
320:130–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tomita S, Kihira Y and Tamaki T:
Pathophysiological responses to hypoxia in vascular remodeling by
hypoxia-inducible factor-1. Seikagaku. 85:265–268. 2013.PubMed/NCBI
|
|
15
|
Pugh CW and Ratcliffe PJ: Regulation of
angiogenesis by hypoxia: role of the HIF system. Nat Med.
9:677–684. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seccareccia E and Brodt P: The role of the
insulin-like growth factor-I receptor in malignancy: An update.
Growth Horm IGF Res. 22:193–199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang Y and Yee D: Targeting insulin and
insulin-like growth factor signaling in breast cancer. J Mammary
Gland Biol Neoplasia. 17:251–261. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dziadziuszko R, Camidge DR and Hirsch FR:
The insulin-like growth factor pathway in lung cancer. J Thorac
Oncol. 3:815–818. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ozkan EE: Plasma and tissue insulin-like
growth factor-I receptor (IGF-IR) as a prognostic marker for
prostate cancer and anti-IGF-IR agents as novel therapeutic
strategy for refractory cases: a review. Mol Cell Endocrinol.
344:1–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu J and Zhu AX: Targeting insulin-like
growth factor axis in hepatocellular carcinoma. J Hematol Oncol.
4:302011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calvisi DF, Frau M, Tomasi ML, Feo F and
Pascale RM: Deregulation of signalling pathways in prognostic
subtypes of hepatocellular carcinoma: Novel insights from
interspecies comparison. Biochim Biophys Acta. 1826:215–237.
2012.
|
|
22
|
Morrione A, Neill T and Iozzo RV:
Dichotomy of decorin activity on the insulin-like growth factor-I
system. FEBS J. 280:2138–2149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferguson RD, Alikhani N, Vijayakumar A,
Fierz Y, Cannata D and Yakar S: IGF-1 cellular action and its
relationship to cancer: evidence from in vitro and in vivo studies.
Insulin-like Growth Factors and Cancer. 12. LeRoith D: Springer;
New York, NY: pp. 105–146. 2012, View Article : Google Scholar
|
|
24
|
Huang X, Zhang QY, Jiang QY, Kang XM and
Zhao L: Polysaccharides derived from Lycium barbarum suppress
IGF-1-induced angiogenesis via PI3K/HIF-1α/VEGF signalling pathways
in MCF-7 cells. Food Chem. 131:1479–1484. 2012. View Article : Google Scholar
|
|
25
|
Slomianya MG, Black LA, Kibbey MM, Day TA
and Rosenzweig SA: IGF-1 induced vascular endothelial growth factor
secretion in head and neck squamous cell carcinoma. Biochem Biophys
Res Commun. 342:851–858. 2006. View Article : Google Scholar
|
|
26
|
Wang F, Liu S, Xi S, Yan L, Wang H, Song Y
and Sun G: Arsenic induces the expressions of angiogenesis-related
factors through PI3K and MAPK pathways in SV-HUC-1 human
uroepithelial cells. Toxicol Lett. 222:303–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
King SM, Modi DA, Eddie SL and Burdette
JE: Insulin and insulin-like growth factor signaling increases
proliferation and hyperplasia of the ovarian surface epithelium and
decreases follicular integrity through upregulation of the
PI3-kinase pathway. J Ovarian Res. 6:122013. View Article : Google Scholar : PubMed/NCBI
|
